Profile
ACRV NVO VRTX REGN SGEN ARGX
Company Name Acrivon Therapeutics, Inc. Common Stock Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $208.92M $459.47B $102.31B $75.85B $43.15B $37.66B
Employees 0.06K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Dr. Peter Blume-Jensen M.D., Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ACRV NVO VRTX REGN SGEN ARGX
Quant Rating Score 2 3 3 4 3 1
Quant Rating Sell Neutral Neutral Buy Neutral Strong Sell
Trading
ACRV NVO VRTX REGN SGEN ARGX
Last Close $6.71 $85 $397.27 $701.85 $228.74 $623.82
High 52 $10.54 $146.91 $516.74 $1201.76 $228.74 $638.33
Low 52 $3.4 $85 $392.81 $701.85 $228.74 $356.01
Price vs. 52 Week High -36.34 % -42.14 % -23.12 % -41.6 % 0 % -2.27 %
Price vs. 52 Week Low 97.35 % 0 % 1.14 % 0 % 0 % 75.23 %
Total Return
ACRV NVO VRTX REGN SGEN ARGX
1 Month Return 2.44 % -19.09 % -11.91 % -4.9 % 0 % 2.95 %
3 Month Return -10.17 % -33.34 % -14.55 % -38.7 % 0 % 17.04 %
6 Month Return 1.51 % -40.12 % -15.24 % -33.36 % 0 % 58.14 %
9 Month Return 9.46 % -34.08 % -4.5 % -27.48 % 0 % 54.84 %
YTD Return 36.38 % -17.83 % -2.36 % -20.09 % 0 % 63.98 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACRV NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.68 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -19.62 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
ACRV NVO VRTX REGN SGEN ARGX
Asset Growth -23.71 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth 51.05 % 32.32 % 9.64 % 6.49 % 22.93 % 190.7 %
Revenue Growth - 31.26 % 10.51 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year - 90.03 % 60.36 % 55.67 % 91.56 % 2071.96 %
Revenue 5 Year - 123.63 % 219.55 % 110.3 % 215.48 % 3041.46 %
Revenue 10 Year - 65.69 % 610.45 % 549.62 % 494.04 % 9009.53 %
EBIT Growth -105.89 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Net Income Growth -103.48 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share -975.3 % 106.26 % 34.59 % 13.48 % -763.59 % 64.01 %
Net Income 5 Yeari Growth Per Share -975.3 % 133.27 % 70.33 % 74.02 % -276.93 % -143.65 %
Net Income 10 Yeari Growth Per Share -975.3 % 98.1 % 809.6 % 871.12 % -624.16 % -857 %
Operating Income Growth -105.89 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) -41.58 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG -1337.31 % 117.73 % 9.63 % 76.95 % -147.99 % 21.71 %
Operating 5 Year CFG -1337.31 % 162.84 % 174.78 % 125.17 % -195.86 % -329.63 %
Operating 10 Year CFG -1337.31 % 150.28 % 6084.35 % 713.56 % -2622.09 % -1280.2 %
EPS Growth -102.96 % 51.88 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth -102.96 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share -29.41 % 28.67 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share 1461.07 % 74.77 % 104.06 % 137.56 % 33.72 % 93.75 %
Share Holder 5 Year Equity Growth Per Share 1461.07 % 121.34 % 291.14 % 219.1 % 220.81 % 318.81 %
Share Holder 10 Year Equity Growth Per Share 1461.07 % 49.24 % 1030.79 % 1286.9 % 691.19 % 3654.06 %
Dividend Per Share Growth - 26.56 % - - - -
Dividend 3 Year Growth Per Share - 63.98 % - - - -
Dividend 5 Year Growth Per Share - 79.57 % - - - -
Dividend 10 Year Growth Per Share - 94.94 % - - - -
Debt Growth -6.39 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth -36.07 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
ACRV NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM 69.59 % 84.66 % 86.1 % 84.42 % 72.37 % 86.82 %
Return on Assets TTM -35.86 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -47.95 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -42.68 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 90.24 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -4527.49 % 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM - 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM - 3.89 6.06 2.27 1.98 3.45
Payables Turnover TTM 0.38 1.72 3.73 4.34 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.71 0.65 0.91
Fixed Asset Turnover TTM 22.25 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 0.88 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -1.59 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -1.67 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 491.94 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM -3220.54 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.1 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM - 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM -3.28 38.84 -87.91 22.46 -141.85 -178.29
Price To Operating Cash Flows Ratio TTM -4.21 22.2 -121.64 17.86 -203.89 -257.55
Price Cash Flow Ratio TTM -4.21 22.2 -121.64 17.86 -203.89 -257.55
Income Statement (TTM)
ACRV NVO VRTX REGN SGEN ARGX
Revenue $0B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $-0B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 0% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.06B $114.63B $4.61B $4.69B $-0.62B $-0.22B
Net Income $-0.06B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -2.74 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
ACRV NVO VRTX REGN SGEN ARGX
Long Term Debt $0B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0.02B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.12B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0.09B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.14B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
ACRV NVO VRTX REGN SGEN ARGX
Net Income $-0.06B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.04B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 3.39
ABCL AbCellera Biologics Inc. 2.85
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.7
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.85
ABSI Absci Corporation 2.99
ABUS Arbutus Biopharma Corporation 3.21
ABVC ABVC BioPharma, Inc. 0.524
ABVX Abivax SA American Depositary Shares 7.65
ACAD ACADIA Pharmaceuticals Inc. 16.87
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9811
ACHV Achieve Life Sciences, Inc. 3.69
ACIU AC Immune SA 2.68
ACLX Arcellx, Inc. 75.54
ACST Acasti Pharma Inc. 3.37
ACXP Acurx Pharmaceuticals, Inc. 0.825
ETFs With Exposure to ACRV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00273 221.92
VTI Vanguard Total Stock Market Index Fund 0 293.28
IBB iShares Biotechnology ETF 0.0133 132.73
SCHB Schwab U.S. Broad Market ETF 0.000454367 22.9
SCHA Schwab U.S. Small-Cap ETF 0.00262412 26
IWN iShares Russell 2000 Value ETF 0.00627 164.11
IWO iShares Russell 2000 Growth ETF 0.00305 290.85
BIB ProShares Ultra Nasdaq Biotechnology 0.00732714 51.41
VXF Vanguard Extended Market Index Fund 0 192.94
HDG ProShares Hedge Replication ETF 0.000423299 49.812
UWM ProShares Ultra Russell2000 0.00116807 42.52
VTHR Vanguard Russell 3000 Index Fund 0 263.02
IWC iShares Micro-Cap ETF 0.01868 129.75
URTY ProShares UltraPro Russell2000 0.00056328 50.52
VTWV Vanguard Russell 2000 Value Index Fund 0.01 145.51
VTWO Vanguard Russell 2000 Index Fund 0 90.05
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 101.62
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 101.6
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.34
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.33
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.33
RYLD Global X Russell 2000 Covered Call ETF 0 16.42
IBBQ Invesco Nasdaq Biotechnology ETF 0.021 21.6
DFAT Dimensional U.S. Targeted Value ETF 0.00011208 55.46
DFAS Dimensional U.S. Small Cap ETF 0.00021931 65.29
DFAC Dimensional U.S. Core Equity 2 ETF 0.00010869 34.82
VTSAX Vanguard Total Stock Market Index Fund 0 142.69
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 146.27
VITSX Vanguard Total Stock Market Index Fund 0 142.71
DFSU Dimensional US Sustainability Core 1 ETF 0.00099089 38.1594
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000104799 99.94
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 146.28
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00356256 35.89
AVSC Avantis U.S. Small Cap Equity ETF 0.01 54.46
VEMPX Vanguard Extended Market Index InstlPlus 0 360.98
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 267.71
RSSL Global X Funds 0 87.16
DXUV Dimensional ETF Trust 0.00003456 53.12
RFLR Innovator ETFs Trust 0.02 25.8322
Unlock